Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD Meeting Abstract

  

Authors:	Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; Singer, N.; West, M.; Penack, O.; Hanash, A. M.; Sant'Angelo, D.; Sadelain, M.; van den Brinks, M. R. M.
Abstract Title:	Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
Meeting Title:	102nd Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	71
Issue:	8 Suppl.
Meeting Dates:	2011 Apr 2-6
Meeting Location:	Orlando, FL
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2011-04-01
Language:	English
ACCESSION:	WOS:000209701300449
DOI:	10.1158/1538-7445.am2011-4743
PROVIDER:	wos
Notes:	Meeting Abstract: 4743 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/99116